Stability of eosinophilic inflammation in COPD bronchial biopsies

E. Haydn Walters, Shakti D. Shukla, Chris Ward

Source: Eur Respir J, 56 (6) 2003802; 10.1183/13993003.03802-2020
Journal Issue: December
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Haydn Walters, Shakti D. Shukla, Chris Ward. Stability of eosinophilic inflammation in COPD bronchial biopsies. Eur Respir J, 56 (6) 2003802; 10.1183/13993003.03802-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Characteristics of eosinophilic and neutrophilic inflammation of bronchi of the bronchial asthma (BA) patients
Source: Eur Respir J 2001; 18: Suppl. 33, 32s
Year: 2001

Clinical outcome of eosinophilic airway inflammation in chronic airway diseases including nonasthmatic eosinophilic bronchitis
Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside
Year: 2017

Clinical and inflammatory determinants of bronchial hyperresponsiveness in COPD
Source: Eur Respir J 2012; 40: 1098-1105
Year: 2012



Measurements of sputum interleukin-5 in chronic obstructive pulmonary disease patients with eosinophilic airway inflammation
Source: Annual Congress 2008 - Phenotyping of asthma and COPD
Year: 2008



Eosinophilic airway inflammation in COPD and asthma
Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation
Year: 2008


Bronchial reversibility and airway inflammation in patients with COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 436s
Year: 2003

Bronchial hyper-responsiveness in chronic eosinophilic pneumonia is not correlated uniquely to local eosinophil infiltration
Source: Eur Respir J 2002; 20: Suppl. 38, 315s
Year: 2002

The pathological feature of airway inflammation in eosinophilic bronchitis
Source: Eur Respir J 2005; 26: Suppl. 49, 282s
Year: 2005

Induced sputum and airway inflammation in asthma and COPD
Source: Annual Congress 2006 - PG14 - Noninvasive monitoring of asthma inflammation and treatment
Year: 2006

CCSP modulates inflammation in bronchial epithelium differentiated ex vivo from bronchial biopsy of COPD patients
Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease
Year: 2010


Correlation between bronchial hyperresponsiveness and bronchial inflammation in asthmatic patients
Source: Eur Respir J 2002; 20: Suppl. 38, 49s
Year: 2002

Eicosanoids and eosinophilic inflammation of airways in stable COPD.
Source: International Congress 2018 – COPD: immune regulation and therapeutic targets
Year: 2018


Modulation of Eosinophilic airway inflammation in COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 441s
Year: 2005

The importance of eosinophilic inflammation in COPD exacerbations
Source: International Congress 2017 – COPD management
Year: 2017

Inflammatory mediators in eosinophilic COPD phenotype and asthma with fixed airflow obstruction
Source: International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases
Year: 2018




Variability of bronchial inflammation in chronic obstructive pulmonary disease: implications for study design
Source: Eur Respir J 2006; 27: 293-299
Year: 2006



Late Breaking Abstract - A GATA3-specific DNAzyme attenuates sputum eosinophilia in COPD patients with eosinophilic airway inflammation
Source: International Congress 2017 – Update and new perspectives in Airway Diseases
Year: 2017

Bronchial vascularity in the airways of chronic bronchitis and COPD smokers
Source: Annual Congress 2010 - COPD and asthma: models and human studies
Year: 2010


Nasal mucosa biopsy in patients with severe bronchial asthma
Source: Annual Congress 2009 - Severe asthma and its treatment
Year: 2009